Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.
Here are today's top performing health care Small-Cap Stars:
Elite Pharms Inc (ELTP) Elite Pharms Inc
gained 8.41% to $0.34
. The gains came on a volume of 1,502,200 shares against an average daily volume of 1,656,971 shares. Elite Pharms Inc
has had a trading range from $0.97
over the last year, it has a 50-day SMA of $0.37
, and a 200-day SMA of $0.32
.Elite Pharmaceuticals Inc
a specialty pharmaceutical company is mainly engaged in the development and manufacture of oral, controlled-release products, using proprietary technology.
Accelerate Diagnostics Inc (AXDX) Accelerate Diagnostics Inc
gained 6.94% to $17.05
. The gains came on a volume of 287,604 shares against an average daily volume of 346,286 shares. Accelerate Diagnostics Inc
has had a trading range from $31.86
over the last year, it has a 50-day SMA of $23.79
, and a 200-day SMA of $17.47
.Accelerate Diagnostics Inc
develops BACcel system, planned for rapid diagnosis in life-threatening infectious pathogens. It has also developed and licensed OptiChem surface coatings for use in microarraying components.
Cerus Corporation (CERS) Cerus Corporation
gained 6.93% to $3.86
. The gains came on a volume of 821,994 shares against an average daily volume of 627,775 shares. Cerus Corporation
has had a trading range from $8.00
over the last year, it has a 50-day SMA of $4.02
, and a 200-day SMA of $5.37
is a biomedical products company, which focuses on commercializing the INTERCEPT Blood System to enhance blood safety.
Chromadex Corp (CDXC) Chromadex Corp
gained 6.2% to $1.37
. The gains came on a volume of 58,980 shares against an average daily volume of 63,431 shares. Chromadex Corp
has had a trading range from $2.15
over the last year, it has a 50-day SMA of $1.37
, and a 200-day SMA of $1.47
through its subsidiaries, supplies phytochemical referance standards to research an array of potential attributes & reference materials, related contract services, technical consulting & proprietary ingredients.
Therapeuticsmd (TXMD) Therapeuticsmd
gained 5.56% to $4.75
. The gains came on a volume of 1,274,280 shares against an average daily volume of 2,640,885 shares. Therapeuticsmd
has had a trading range from $9.01
over the last year, it has a 50-day SMA of $4.57
, and a 200-day SMA of $5.07
is a specialty pharmaceutical company. It develops and markets branded prescription, generic prescription, and over-the-counter (non-prescription) products exclusively for women.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.Equities.com
's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.
All data provided by QuoteMedia and was accurate as of 4:30 pm ET.